World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 25 July 2023
Main ID:  ISRCTN65771265
Date of registration: 27/06/2016
Prospective Registration: Yes
Primary sponsor: Johns Hopkins Bloomberg School of Public Health
Public title: Nguvu: Evaluating an integrated approach to reduce intimate partner violence and psychological distress in refugees in Tanzania
Scientific title: Nguvu: A randomized controlled trial of an integrated intervention to reduce intimate partner violence and psychological distress in adult, female Congolese refugees in Tanzania
Date of first enrolment: 03/04/2017
Target sample size: 311
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN65771265
Study type:  Interventional
Study design:  Study design as of 31/10/2018: Single-centre randomized pilot controlled trial Previous study design: Single-centre randomized controlled trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Tanzania
Contacts
Name: M. Claire    Greene
Address:  Johns Hopkins Bloomberg School of Public Health 624 North Broadway, Rm. 888 21205 Baltimore United States of America
Telephone:
Email:
Affiliation: 
Name: Wietse A.    Tol
Address:  Johns Hopkins Bloomberg School of Public Health 624 North Broadway, Rm. 863 21205 Baltimore United States of America
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria as of 29/03/2017:
1. Aged 18 years and over
2. Female
3. Refugee from the Democratic Republic of the Congo (DRC) currently residing in Nyarugusu Refugee Camp, Tanzania
4. Participating in a local women’s groups
5. Past-years history of intimate partner violence: endorsing any past-year intimate partner violence on a modified version of the Abuse Assessment Screen (AAS)
6. Experiencing moderate-severe psychological distress: Average score of moderate to severe (=1.75 out of 4) on items assessing depressive or anxiety symptoms; or = 1.0 out of 3 on items assessing post-traumatic stress symptoms. Depressive and anxiety symptoms were measured using the 25-item Hopkins Symptom Checklist (HSCL). Post-traumatic stress symptoms were measured using the 16-item Harvard Trauma Questionnaire (HTQ)

Original inclusion criteria 4-5:
4. Past-years history of intimate partner violence: endorsing any past-year intimate partner violence on a modified version of the Abuse Assessment Screen (AAS)
5. Experiencing moderate-severe psychological distress: Average score of moderate to severe (>1.75 out of 4) on items assessing depressive, anxiety or post-traumatic stress symptoms. Depressive and anxiety symptoms were measured using the 25-item Hopkins Symptom Checklist (HSCL). Post-traumatic stress symptoms were measured using the 16-item Harvard Trauma Questionnaire (HTQ).

Exclusion criteria: 1. Serious mental illness
2. Substance use disorder
3. Imminent risk of suicide


Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Psychological distress (e.g. depressive, anxiety or post-traumatic stress symptoms) in refugees with a past-year history of intimate partner violence
Mental and Behavioural Disorders
Psychological distress (e.g. depressive, anxiety or post-traumatic stress symptoms) in refugees with a past-year history of intimate partner violence
Intervention(s)
Correct as of 12/06/2017:
Nyarugusu is divided into 7 zones for Congolese refugees, which are further subdivided into 52 total villages.

One of the zones (zone 1) will be excluded from the trial because it was used as the site for the pilot study. In zones 2-7 there are 59 women’s groups organized within the villages, which will serve as the cluster and source of recruitment for the study.

Staff not working for the project at Johns Hopkins Bloomberg School of Public Health will randomize women’s groups in zones 2-7 into the intervention and control condition using approximately a 1:1 allocation ratio through a random number generator in the Stata. The allocation of villages to intervention and control condition will be concealed from the local research assistants.

Intervention (Nguvu) Arm: Participants will have access to the Nguvu intervention, which is an 8-week program that integrates advocacy and empowerment counseling with cognitive processing therapy. The intervention was developed from previous programs evaluated in survivors of sexual and gender-based violence and adapted through formative research conducted in Nyarugusu refugee camp. The intervention consists of weekly sessions over the course of 8 weeks (1 individual session followed by 7 group sessions). Sessions 1 and 8 are the advocacy sessions, which focus on developing a safety plan and discussing issues surrounding intimate partner violence and psychological distress. Sessions 2-7 are the cognitive processing therapy sessions that introduce concepts and the relationship between thoughts and feelings and teach participants skills to identify stuck thoughts and introduce skills to change thinking errors as a means to improve feelings and reduce psychological stress.

Comparison group: Participants will
Primary Outcome(s)
Primary outcome measures as of 07/11/2018:
1. Relevance of the intervention and research protocols
1.1. To determine whether psychological distress is a prevalent problem that is prioritized by women affected by intimate partner violence in refugee settings
1.2. To evaluate the validity and reliability of mental health, violence and functioning outcome measures in the study population
2. Acceptability of the intervention and research protocols
2.1. Participant retention in intervention sessions and research interviews (75% of intervention sessions attended, on average; 85% retention in post-treatment assessment)
2.2. No serious adverse events related to study participation
2.3. Safety and ethical concerns reported in qualitative interviews with participants and program staff
3. Feasibility of the intervention and research protocols
3.1. Fidelity of intervention implementation as determined through supervision, qualitative interviews with intervention facilitators and routine monitoring for protocol deviations
3.2. Recruitment of 15 groups of eligible women (approximately n=150-180) and approximately equal number of controls within 3 months
3.3. Balanced randomization groups on demographics and baseline levels of outcome measures
3.4. Implementation challenges reported in qualitative interviews with program staff and partner agency representatives, changes in anticipated timelines, etc.
3.5. Monitoring of research protocol deviations to inform adaptations to recruitment, randomization, assessment, and follow-up procedures

Previous primary outcome measures:
1. Recurrence of intimate partner violence is measured using the Domestic Violence Module of the Demographic and Health Survey at baseline, 9 and 20 weeks post-enrollment
2. Psychological distress symptoms are measured using the 25-item Hopkins Symptom Checklist (HSCL-25) and PTSD Symptom Items in the Harvard Trauma Questionnaire (HTQ) at baseline, 9 and 20 weeks post-enrollment
Secondary Outcome(s)
Secondary outcome measures as of 07/11/2018:
1. Recurrence of intimate partner violence as measured using the Domestic Violence Module of the Demographic and Health Survey at baseline and post-treatment assessments
2. Psychological distress symptoms as measured using the 25-item Hopkins Symptom Checklist (HSCL-25) and PTSD symptom items in the Harvard Trauma Questionnaire at baseline and post-treatment assessments
3. Functional impairment as measured using 12 items developed from qualitative data at baseline and post-treatment assessments

Previous secondary outcome measures:
Functional impairment measured using 12 items developed from qualitative data at baseline, 9 and 20 weeks post-enrollment
Secondary ID(s)
N/A
Nil known
Source(s) of Monetary Support
Wellcome Trust, Department for International Development
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Old ethics approval format; 1. Johns Hopkins Bloomberg School of Public Health, 20/09/2016, ref: 00007219 2. Muhimbili University of Health and Allied Sciences, Tanzania, 20/10/2015, ref: 2014-10-27/AEC/Vol.X/56 3. National Institute of Medical Research, Tanzania, 11/09/2015 ref: NIMR/HQ/R.8a/Vol.1X/2016
Results
Results available: Yes
Date Posted:
Date Completed: 01/10/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history